PAD TECHNOLOGY
LIVE

Serial Number

79313408

Owner

MC2 Therapeutics A/S

Attorney

Meichelle R. MacGregor

Filing Date

Mar 5, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PAD TECHNOLOGY Trademark

Serial Number: 79313408 • Registration: 6903308

PAD TECHNOLOGY is a trademark filed by MC2 Therapeutics A/S on March 5, 2021. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

MC2 Therapeutics A/S (5 trademarks)

Agern Alle 24 - 26

Entity Type: 65

Trademark Details

Filing Date

March 5, 2021

Registration Date

November 22, 2022

Published for Opposition

September 6, 2022

Goods & Services

Pharmaceutical preparations, namely, pharmaceutical creams in the nature of medicated creams for treating dermatological conditions, pharmaceutical preparations for the treatment of dermatological condition, skin lotions for medical purposes; pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment of dermatological condition; veterinary preparations for treatment of dermatological condition; sanitary preparations for medical use, dietetic substances adapted for medical use, namely, Dietetic preparations adapted for medical purposes; chemical preparations for medical use, namely, for treatment of dermatological condition

Cosmetics, namely, cosmetic preparations for skincare, moisturizing preparations for the skin; face, body, hand moisturizers, cosmetics, natural cosmetics, organic cosmetics, body lotions, non-medicated cosmetic preparations

Medical services, namely, health care information, health care consultancy, medical and health care services consultancy, provision of medical information in the health system; veterinary services; health and beauty care for humans and animals; medical care; animal healthcare services

Medical, scientific and industrial research in the field of dermatology; pharmaceutical research services

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 16, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 5, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 15, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 15, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 22, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 22, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 22, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 6, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 6, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 17, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2022 CRFA
ASSIGNED TO LIE
Jul 8, 2022 ALIE
NOTICE OF REVIVAL - E-MAILED
Jun 23, 2022 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2022 TROA
PETITION TO REVIVE-GRANTED
Jun 23, 2022 PETG
TEAS PETITION TO REVIVE RECEIVED
Jun 23, 2022 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 9, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 9, 2022 ABN2
REFUSAL PROCESSED BY IB
Nov 15, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 24, 2021 RFCS
REFUSAL PROCESSED BY MPU
Oct 21, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 29, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 28, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 26, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 17, 2021 REPR